1.888.321.7828 sales@pepid.com

New study shows C-reactive protein (CRP) testing in primary care clinics for patients with Chronic Obstructive Pulmonary Disease (COPD) reduces patient reported antibiotic use or receiving antibiotic prescriptions for exacerbation of COPD with no evidence of harm.

Read the full report from the New England Journal of Medicine here.

Read PEPID’s Serum CRP Measurement Lab here.